Related references
Note: Only part of the references are listed.Current state of therapeutic focused ultrasound applications in neuro-oncology
Ying Meng et al.
JOURNAL OF NEURO-ONCOLOGY (2022)
Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review
Isis Oliveira Menezes et al.
PHYTOMEDICINE (2021)
Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide (vol 10, 581814, 2020)
Monserrat Llaguno-Munive et al.
FRONTIERS IN ONCOLOGY (2021)
Targeted Delivery of Liposomal Temozolomide Enhanced Anti-Glioblastoma Efficacy through Ultrasound-Mediated Blood-Brain Barrier Opening
Zhuqing Song et al.
PHARMACEUTICS (2021)
Simultaneous binding mechanism of multiple substrates for multidrug resistance transporter P-glycoprotein
Bo Zhang et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)
Triolein emulsion enhances temozolomide brain delivery: an experimental study in rats
Won-Bae Seung et al.
DRUG DELIVERY (2021)
Z-ligustilide: A review of its pharmacokinetics and pharmacology
Qingxuan Xie et al.
PHYTOTHERAPY RESEARCH (2020)
Brachyury Is Associated with Glioma Differentiation and Response to Temozolomide
Filipe Pinto et al.
NEUROTHERAPEUTICS (2020)
The Protective Effects and Potential Mechanisms of Ligusticum chuanxiong: Focus on Anti-Inflammatory, Antioxidant, and Antiapoptotic Activities
Jinhui Shi et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Computational Insights into Allosteric Conformational Modulation of P-Glycoprotein by Substrate and Inhibitor Binding
Juan Xing et al.
MOLECULES (2020)
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
Costas D. Arvanitis et al.
NATURE REVIEWS CANCER (2020)
MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression
YiHan Wu et al.
BIOSCIENCE REPORTS (2019)
The influence and mechanism of ligustilide, senkyunolide I, and senkyunolide A on echinacoside transport through MDCK-MDR1 cells as blood-brain barrier in vitro model
Qin Zheng et al.
PHYTOTHERAPY RESEARCH (2018)
Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2
Mark C. de Gooijer et al.
NEOPLASIA (2018)
Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier
Martina Da Ros et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
Shabierjiang Jiapaer et al.
NEUROLOGIA MEDICO-CHIRURGICA (2018)
Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage
Wen-Jian Liu et al.
ONCOTARGETS AND THERAPY (2018)
Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent
Qian Dong et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: optimization, characterization, and evaluation in vitro and in vivo
Kai Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy
Lijuan Wen et al.
DRUG DELIVERY (2017)
β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1
Nanbu Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Elucidation of Transport Mechanism of Paeoniflorin and the Influence of Ligustilide, Senkyunolide I and Senkyunolide A on Paeoniflorin Transport through Mdck-Mdr1 Cells as Blood-Brain Barrier in Vitro Model
Peng-Yi Hu et al.
MOLECULES (2016)
Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins
Meimei Duan et al.
PHARMACEUTICAL BIOLOGY (2016)
Nephroprotective effects of ferulic acid, Z-ligustilide and E-ligustilide isolated from Angelica sinensis against cisplatin toxicity in vitro
Valerian Bunel et al.
TOXICOLOGY IN VITRO (2015)
Automatic cervical cell segmentation and classification in Pap smears
Thanatip Chankong et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2014)
Essential oil from Zanthoxylum bungeanum Maxim. and its main components used as transdermal penetration enhancers: a comparative study
Yi Lan et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2014)
Combination of photodynamic therapy and temozolomide on glioma in a rat C6 glioma model
Xiaoming Zhang et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2014)
Function of the Blood-Brain Barrier and Restriction of Drug Delivery to Invasive Glioma Cells: Findings in an Orthotopic Rat Xenograft Model of Glioma
Sagar Agarwal et al.
DRUG METABOLISM AND DISPOSITION (2013)
Whole-Body Diffusion-weighted MR Imaging in Cancer: Current Status and Research Directions
Anwar R. Padhani et al.
RADIOLOGY (2011)
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
M. Schaich et al.
ANNALS OF ONCOLOGY (2009)
Effect of adhesive matrix composition and terpinolene on indomethacin bioavailability in rats from transdermal therapeutic system
Krzysztof Cal et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2008)
Flavor components of monoterpenes in citrus essential oils enhance the release of monoamines from rat brain slices
Syuichi Fukumoto et al.
NUTRITIONAL NEUROSCIENCE (2006)
Disposition and pharmacokinetics of temozolomide in rat
L Reyderman et al.
XENOBIOTICA (2004)
P-glycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists
CP Chen et al.
DRUG METABOLISM AND DISPOSITION (2003)
Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates
M Patel et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Drug efflux transporters in the CNS
HY Sun et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)